You are currently accessing Global Competition Review via your firmwide account.
If you would like to login via a personal account, please use the link below. Log in
07 June 2018
The UK’s Competition Appeal Tribunal has overturned a €101.5 million fine on Pfizer and Flynn Pharma for excessively pricing an epilepsy drug.
View all events
Copyright © Law Business Research
Company Number: 03281866 VAT: GB 160 7529 10